Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and Clinical Aspects of Mild Cognitive Impairment in Parkinson's Disease: A Meta‐Analysis
Chiara Baiano, Paolo Barone, Luigi Trojano, et al.
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 45-54
Closed Access | Times Cited: 241

Showing 51-75 of 241 citing articles:

Impulse control and related behavioral disorders in Parkinson’s disease. Risk factors, diagnosis, and management. Is there a possible role for non-invasive brain stimulation?
Stefano Terruzzi, Lina Urh, Daniele Piscitelli, et al.
Neurological Sciences (2025)
Closed Access
The Role of Semaphorin 3 A in the Pathogenesis and Progression of Alzheimer’s Disease and Other Aging-Related Diseases: A Comprehensive Review
Jing Yuan, Rui Huang, Jianfei Nao, et al.
Pharmacological Research (2025), pp. 107732-107732
Open Access
Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease
Mattia Siciliano, Lugi Trojano, Rosa De Micco, et al.
Journal of Neurology (2021)
Open Access | Times Cited: 30
Topologically convergent and divergent morphological gray matter networks in early‐stage Parkinson's disease with and without mild cognitive impairment
Xueling Suo, Du Lei, Nannan Li, et al.
Human Brain Mapping (2021) Vol. 42, Iss. 15, pp. 5101-5112
Open Access | Times Cited: 30
The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease
Hailing Liu, Bin Deng, Fen Xie, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 9, pp. 1917-1934
Open Access | Times Cited: 29
Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach—A Comprehensive Narrative Review
Sara Uceda, Víctor Echeverry‐Alzate, Manuel Reiriz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13294-13294
Open Access | Times Cited: 12
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Johann Faouzi, Manuela Tan, Fanny Casse, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Mild cognitive impairment in Parkinson's disease: current view
K. A. Jellinger
Frontiers in Cognition (2024) Vol. 3
Open Access | Times Cited: 4
Kinematic and Kinetic Gait Features Associated With Mild Cognitive Impairment in Parkinson’s Disease
Michela Russo, Marianna Amboni, Antonio Volzone, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering (2024) Vol. 32, pp. 2676-2687
Open Access | Times Cited: 4
The role of APOE in cognitive trajectories and motor decline in Parkinson’s disease
Sungyang Jo, Seon‐Ok Kim, Kye Won Park, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Region-Specific Neurovascular Decoupling Associated With Cognitive Decline in Parkinson’s Disease
Song’an Shang, Hongying Zhang, Yuan Feng, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 25
Effects of cognitive rehabilitation in Parkinson disease: a meta-analysis
Andreina Giustiniani, Lorenza Maistrello, Laura Danesin, et al.
Neurological Sciences (2022) Vol. 43, Iss. 4, pp. 2323-2337
Closed Access | Times Cited: 18
Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease
Javier Pagonabarraga, Rocío Pérez‐González, Helena Bejr‐Kasem, et al.
Parkinsonism & Related Disorders (2022) Vol. 105, pp. 132-138
Closed Access | Times Cited: 18
Microstructural but not macrostructural cortical degeneration occurs in Parkinson’s disease with mild cognitive impairment
Xueqin Bai, Tao Guo, Jingwen Chen, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Altered Intra- and Inter-Network Connectivity in Drug-Naïve Patients With Early Parkinson’s Disease
Weiqi Zeng, Wenliang Fan, Xiangchuang Kong, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 17
Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson’s disease
Kyum‐Yil Kwon, Suyeon Park, Rae On Kim, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling
Zhu-qing He, Peng-fei Huan, Li Wang, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 4, pp. 1057-1070
Open Access | Times Cited: 16
Effect of cognitive reserve on cognitive function in Parkinson’s disease
Lihua Gu, Hui Xu
Neurological Sciences (2022) Vol. 43, Iss. 7, pp. 4185-4192
Closed Access | Times Cited: 16
EFFECTS OF ROUTINE PHYSICAL THERAPY WITH AND WITHOUT HIGH INTENSITY INTERVAL TRAINING ON BALANCE, QUALITY OF LIFE AND FUNCTION IN PARKINSON’S DISEASE PATIENTS
Muhammad Junaid Tahir, Komal Tehzeeb, Farah Javaid, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2023), pp. 483-490
Open Access | Times Cited: 10
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks
K. A. Jellinger
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 498-498
Open Access | Times Cited: 10
Application of Periventricular White Matter Hyperintensities Combined with Homocysteine into Predicting Mild Cognitive Impairment in Parkinson’s Disease
Zuowen Zhang, Shishuang Li, Shu‐Mei Wang
International Journal of General Medicine (2023) Vol. Volume 16, pp. 785-792
Open Access | Times Cited: 9
Normal cognition in Parkinson's disease may involve hippocampal cholinergic compensation: An exploratory PET imaging study with [18F]-FEOBV
Camille Legault-Denis, Meghmik Aghourian, Jean‐Paul Soucy, et al.
Parkinsonism & Related Disorders (2021) Vol. 91, pp. 162-166
Closed Access | Times Cited: 21
Effect of mobile health intervention for self-management on self-efficacy, motor and non-motor symptoms, self-management, and quality of life in people with Parkinson's disease: Randomized controlled trial
Yusun Park, Sung Reul Kim, Hui Young So, et al.
Geriatric Nursing (2022) Vol. 46, pp. 90-97
Closed Access | Times Cited: 15
Excessive Daytime Sleepiness in Parkinson’s Disease
Hanshu Liu, Jingwen Li, Xinyi Wang, et al.
Nature and Science of Sleep (2022) Vol. Volume 14, pp. 1589-1609
Open Access | Times Cited: 15
Magnetic Resonance Imaging Markers for Cognitive Impairment in Parkinson’s Disease: Current View
Yanbing Hou, Huifang Shang
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 14

Scroll to top